Deutarserine clinical trials
Also written CTP-692.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How each study uses deutarserine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- CTP-692
- 4
Studies by the year they started
4 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses deutarserine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With SchizophreniaCompletedPhase 2Concert PharmaceuticalsNCT04158687Written as CTP-692
- Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy VolunteersCompletedPhase 1Concert PharmaceuticalsNCT03830463Written as CTP-692
- Multiple Ascending Dose Study of CTP-692 in Healthy VolunteersCompletedPhase 1Concert PharmaceuticalsNCT03880253Written as CTP-692
- A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy VolunteersCompletedPhase 1Concert PharmaceuticalsNCT03778320Written as CTP-692
Codes
What other systems call deutarserine · ClinicalTrials.gg INT017471
- UNII (FDA) OD54L0MH86DEUTARSERINEOne source FDA
- NCI Thesaurus C177091DeutarserineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | OD54L0MH86 | DEUTARSERINE | One source FDA |
| NCI Thesaurus | C177091 | Deutarserine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.